AS

Ashu Singla

Active Director Director DIN 10312921
DIN 10312921 First appointment Sep 2023 Primary industry Wood
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Total affiliations 3 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashu Singla

Data last updated:

Ashu Singla is a Director at Omexa Scb Private Limited (since 2025), Director at Glofresh Private Limited (since 2024) and Director at Omexa Formulary Private Limited (since 2023). The companies operate in Wood and Pharma.

DIN 10312921
Primary Designation Director
Industry Wood
First Appointment 09 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Omexa Scb Private Limited U21002TN2025PTC179960
Director29 Apr 20252025Active
Glofresh Private Limited U20237TN2024PTC169013
Director01 Apr 20242024Active
Omexa Formulary Private Limited U21001PB2023PTC058767
Director09 Sep 20232023Active

Board colleagues of Ashu Singla

Directorship timeline

Open interactive timeline →
Omexa Scb Private Limited
Glofresh Private Limited
Omexa Formulary Private Limited
Premium access

Shareholding and investment profile for Ashu Singla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashu Singla

Ashu Singla currently holds 3 directorships: Omexa Scb Private Limited (Director, since 29 Apr 2025); Glofresh Private Limited (Director, since 01 Apr 2024); Omexa Formulary Private Limited (Director, since 09 Sep 2023).

Ashu Singla was first appointed on 09 Sep 2023 as Director at Omexa Formulary Private Limited. The most recent appointment on record is 29 Apr 2025 at Omexa Scb Private Limited.

The current boards of Ashu Singla's companies include Ekambaranathan Ramanathan (Omexa Scb Private Limited), Gurjeet Kaur (Omexa Formulary Private Limited), Nathan Kannan Ramanathan (Omexa Formulary Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available